cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2021-2953cardiovascular-2953Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEW ARTICLESCOVID-19 и сердечно-сосудистая коморбидность: поиск новых подходов к снижению смертностиCOVID-19 and cardiovascular comorbidity: novel approaches to reduce mortalityhttps://orcid.org/0000-0001-8430-6215БуноваС. С.BunovaS. S.

Светлана Сергеевна Бунова — доктор медицинских наук, профессор кафедры семейной медицины

Bunova Svetlana Sergeevna - Doctor of Medical Sciences, Professor, Professor at the Department of Family Medicine

ssbunova@mail.ruhttps://orcid.org/0000-0002-5330-4783ОхотниковаП. И.OkhotnikovaP. I.

Полина Игоревна Охотникова — ординатор кафедры факультетской терапии и гастроэнтерологии

Okhotnikova Polynya Igorevna - Resident in cardiology of the Department of Faculty Therapy and Gastroenterology

PolyaZ-13_17@mail.ruhttps://orcid.org/0000-0002-6225-2444СкирденкоЮ. П.SkirdenkoYu. P.

Юлия Петровна Скирденко — кандидат медицинских наук, доцент кафедры факультетской терапии и гастроэнтерологии

Skirdenko Yuliya Petrovna - Candidate of Medical Sciences, Associate Professor at the Department of Faculty Therapy and Gastroenterology

julija-loseva1@yandex.ruhttps://orcid.org/0000-0002-3758-4930НиколаевН. А.NikolaevN. A.

Николай Анатольевич Николаев — доктор медицинских наук, доцент, профессор кафедры факультетской терапии и гастроэнтерологии

Nikolaev Nikolay Anatol'evich - Doctor of Medical Sciences, Docent, Professor at the Department of Faculty Therapy and Gastroenterology. 

niknik.67@mail.ruhttps://orcid.org/0000-0002-7321-6529ОсиповаО. А.OsipovaO. A.

Ольга Александровна Осипова — доктор медицинских наук, профессор кафедры госпитальной терапии Медицинского института

Osipova Olga Aleksandrovna - Department of  Hospital Therapy, Doctor of Medical Sciences, Professor

osipova@bsu.edu.ruhttps://orcid.org/0000-0001-7648-0774ЖернаковаН. И.ZhernakovaN. I.

Нина Ивановна Жернакова — доктор медицинских наук, профессор, зав. кафедрой семейной медицины.

Тел.: +7 (915) 560-59-90

Zhernakova Nina Ivanovna - Doctor of Medical Sciences, Professor, Head of the Department of Family Medicine

Zhernakova@bsu.edu.ruФГАОУ ВО Белгородский национальный исследовательский университетBelgorod State UniversityФГБОУ ВО Омский государственный медицинский университет Минздрава РоссииOmsk State Medical UniversityФГБОУ ВО Омский государственный медицинский университет Минздрава РоссииOmsk State Medical University Omsk20211707202120429532953Copyright © Бунова С.С., Охотникова П.И., Скирденко Ю.П., Николаев Н.А., Осипова О.А., Жернакова Н.И., 20212021Бунова С.С., Охотникова П.И., Скирденко Ю.П., Николаев Н.А., Осипова О.А., Жернакова Н.И.Bunova S.S., Okhotnikova P.I., Skirdenko Y.P., Nikolaev N.A., Osipova O.A., zhernakova N.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/2953

Сердечно-сосудистые заболевания (ССЗ) остаются ведущей причиной смерти во всем мире и оказывают значимое влияние на качество жизни пациентов и социально-экономические аспекты. Многочисленные отчеты неизменно демонстрируют, что болезни системы кровообращения являются одним из основных факторов риска увеличения тяжести новой коронавирусной инфекции (COVID-19, CoronaVIrus Disease 2019), включая более высокие риски госпитализаций и внутрибольничной смертности. В условиях текущей пандемии сопровождение пациентов с кардиоваскулярной патологией требует особо пристального внимания врачей. В настоящее время появляется все больше сообщений о долгосрочных эффектах COVID-19. Отдаленные последствия заболевания для здоровья сердечно-сосудистой системы миллионов людей, переживших инфекцию, в настоящий момент неизвестны. Цель обзора — систематизация накопленных знаний о взаимном влиянии COVID-19 и ССЗ. Рассматриваются особенности воздействия ССЗ на течение и исходы COVID-19, причины ухудшения течения кардиоваскулярной патологии у больных коронавирусной инфекцией. Обсуждается влияние перераспределения ресурсов здравоохранения и масштабных мер изоляции на курацию пациентов с ССЗ. Также в обзоре представлены наиболее актуальные данные о постковидном синдроме. Выделены предикторы затяжного течения заболевания для стратификации риска с целью своевременной реализации профилактических мер и разработки индивидуализированного лечения. Авторы были сосредоточены на поиске новых подходов к снижению смертности от ССЗ в условиях пандемии.

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and significantly affect patient quality of life and socioeconomic status. Numerous reports consistently demonstrate that CVDs are a major risk factor for severe course of coronavirus disease 2019 (COVID-19), including higher risks of hospitalizations and inpatient mortality. In the context of the current pandemic, managing patients with CVDs requires special attention from doctors. There are now more and more reports of the long-term effects of COVID-19. The long-term effects on cardiovascular system of millions of COVID-19 survivors are currently unknown. The aim of the review was to systematize the accumulated knowledge about the mutual influence of COVID-19 and CVDs. The features of CVD impact on the course and outcomes of COVID-19, as well as the reasons for the worsening of CVD course in patients with COVID-19 are considered. The impact of redistribution of health care resources and large-scale isolation measures on the management of patients with CVDs is discussed. The review also presents the most relevant data on long COVID. Predictors of a long-term disease course were identified for risk stratification in order to timely implement preventive measures and develop an individualized treatment. The authors focused on finding novel approaches to reduce CVD mortality during a pandemic.

коронавирусная инфекцияCOVID-19SARSCoV-2постковидный синдромкоморбидностьзаболевания сердечно-сосудистой системыcoronavirus infectionCOVID-19SARS-CoV-2long COVIDcomorbiditycardiovascular diseasesReferencesJHU. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://coronavirus.jhu.edu/map.html (11 June 2021).JHU. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://coronavirus.jhu.edu/map.html (11 June 2021).Министерство здравоохранения Российской Федерации. Карта распространения коронавируса в стране. https://covid19.rosminzdrav.ru (11 июня 2021).Ministry of Health of the Russian Federation. Map of the spread of coronavirus in the country. (In Russ.) Министерство здравоохранения Российской Федерации. Карта распространения коронавируса в стране. https://covid19.rosminzdrav.ru (11 июня 2021).Мамедов М. Н., Родионова Ю.В., Явелов И.С. и др. Коронавирусная инфекция с точки зрения междисциплинарного подхода. Круглый стол. Кардиоваскулярная терапия и профилактика. 2021;20(3):2849. doi:10.15829/1728-8800-2021-2849.Mamedov MN, Rodionova YuV, Yavelov IS, et al. COVID-19 from the interdisciplinary standpoint. Round table. Cardiovascular Therapy and Prevention. 2021;20(3):2849. (In Russ.) doi:10.15829/1728-8800-2021-2849.Драпкина О. М., Карпов О. Э., Лукьянов М. М. и др. Проспективный госпитальный регистр больных с предполагаемыми или подтвержденными коронавирусной инфекцией COVID-19 и внебольничной пневмонией (ТАРГЕТ-ВИП): характеристика включенных больных и оценка исходов стационарного этапа лечения. Кардиоваскулярная терапия и профилактика. 2020;19(6):2727. doi:10.15829/1728-8800-2020-2727.Drapkina OM, Karpov OE, Lukyanov MM, et al. Prospective inhospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes. Cardiovascular Therapy and Prevention. 2020;19(6):2727. (In Russ.) doi:10.15829/1728-8800-2020-2727.Pranata R, Huang I, Lim MA, et al. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29(8):104949. doi:10.1016/j.jstrokecerebrovasdis.2020.104949.Pranata R, Huang I, Lim MA, et al. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29(8):104949. doi:10.1016/j.jstrokecerebrovasdis.2020.104949.Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020;45(6):1270-82. doi:10.1007/s10900-020-00920-x.Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020;45(6):1270-82. doi:10.1007/s10900-020-00920-x.Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19. Circulation. 2020;142(1):68-78. doi:10.1161/CIRCULATIONAHA.120.047549.Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19. Circulation. 2020;142(1):68-78. doi:10.1161/CIRCULATIONAHA.120.047549.Федеральная служба государственной статистики. Оперативные демографические показатели за январь-октябрь 2020 г. https://rosstat.gov.ru/folder/12781Federal state statistics service. Operational demographic indicators for January — October 2020. (11 June 2021). (In Russ.) https://rosstat.gov.ru/folder/12781Woolley I. Coronavirus disease 2019 (COVID-19): not one epidemic but four. Intern Med J. 2020;50(6):657-8. doi:10.1111/imj.14866.Woolley I. Coronavirus disease 2019 (COVID-19): not one epidemic but four. Intern Med J. 2020;50(6):657-8. doi:10.1111/imj.14866.Butt JH, Fosbøl EL, Gerds T, et al. All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J. 2021;ehab028. doi:10.1093/eurheartj/ehab028.Butt JH, Fosbøl EL, Gerds T, et al. All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J. 2021;ehab028. doi:10.1093/eurheartj/ehab028.Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-22. doi:10.1002/jmv.26368.Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-22. doi:10.1002/jmv.26368.Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052. doi:10.1001/jama.2020.6775.Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052. doi:10.1001/jama.2020.6775.O’Hearn M, Liu J, Cudhea F, et al. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis. J Am Heart Assoc. 2021;10(5). doi:10.1161/JAHA.120.019259.O’Hearn M, Liu J, Cudhea F, et al. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis. J Am Heart Assoc. 2021;10(5). doi:10.1161/JAHA.120.019259.Арутюнов Г. П., Тарловская Е. И., Арутюнов А. Г. и др. Международный регистр “Анализ динамики Коморбидных заболеваний у пациентов, перенесшИхинфицироВание SARS-CoV-2” (AКТИВ SARS-CoV-2): анализ предикторов неблагоприятных исходов острой стадии новой коронавирусной инфекции. Российский кардиологический журнал. 2021;26(4):4470. doi:10.15829/1560-4071-2021-4470.Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russ J Cardiol. 2021;26(4):4470. (In Russ.) doi:10.15829/1560-4071-2021-4470.Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802. doi:10.1001/jamacardio.2020.0950.Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802. doi:10.1001/jamacardio.2020.0950.Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clínica Española (English Ed). 2020;220(8):480-94. doi:10.1016/j.rceng.2020.07.003.Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clínica Española (English Ed). 2020;220(8):480-94. doi:10.1016/j.rceng.2020.07.003.Hessami A, Shamshirian A, Heydari K, et al. Cardiovascular diseases burden in COVID-19: Systematic review and metaanalysis. Am J Emerg Med. 2020. doi:10.1016/j.ajem.2020.10.022.Hessami A, Shamshirian A, Heydari K, et al. Cardiovascular diseases burden in COVID-19: Systematic review and metaanalysis. Am J Emerg Med. 2020. doi:10.1016/j.ajem.2020.10.022.Gu T, Chu Q, Yu Z, et al. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study. BMJ Open. 2020;10(9):e038976. doi:10.1136/bmjopen-2020-038976.Gu T, Chu Q, Yu Z, et al. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study. BMJ Open. 2020;10(9):e038976. doi:10.1136/bmjopen-2020-038976.Yang H, Liang X, Xu J, et al. Meta-Analysis of Atrial Fibrillation in Patients With COVID-19. Am J Cardiol. 2021;144:152-6. doi:10.1016/j.amjcard.2021.01.010.Yang H, Liang X, Xu J, et al. Meta-Analysis of Atrial Fibrillation in Patients With COVID-19. Am J Cardiol. 2021;144:152-6. doi:10.1016/j.amjcard.2021.01.010.Kytömaa S, Hegde S, Claggett B, et al. Association of Influenzalike Illness Activity With Hospitalizations for Heart Failure. JAMA Cardiol. 2019;4(4):363. doi:10.1001/jamacardio.2019.0549.Kytömaa S, Hegde S, Claggett B, et al. Association of Influenzalike Illness Activity With Hospitalizations for Heart Failure. JAMA Cardiol. 2019;4(4):363. doi:10.1001/jamacardio.2019.0549.Yonas E, Alwi I, Pranata R, et al. Effect of heart failure on the outcome of COVID-19 — A meta-analysis and systematic review. Am J Emerg Med. 2020;S0735-6757(20)30602-1. doi:10.1016/j.ajem.2020.07.009.Yonas E, Alwi I, Pranata R, et al. Effect of heart failure on the outcome of COVID-19 — A meta-analysis and systematic review. Am J Emerg Med. 2020;S0735-6757(20)30602-1. doi:10.1016/j.ajem.2020.07.009.Ayoubkhani D, Khunti K, Nafilyan V, et al. Epidemiology of postCOVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. MedRxiv. 2021. doi:10.1101/2021.01.15.21249885.Ayoubkhani D, Khunti K, Nafilyan V, et al. Epidemiology of postCOVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. MedRxiv. 2021. doi:10.1101/2021.01.15.21249885.Lindner D, Fitzek A, Bräuninger H, et al. Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5(11):1281-5. doi:10.1001/jamacardio.2020.3551.Lindner D, Fitzek A, Bräuninger H, et al. Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5(11):1281-5. doi:10.1001/jamacardio.2020.3551.Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and Cardiovascular Disease. Circ Res. 2021;128(8):1214-36. doi:10.1161/CIRCRESAHA.121.317997.Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and Cardiovascular Disease. Circ Res. 2021;128(8):1214-36. doi:10.1161/CIRCRESAHA.121.317997.Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.Yokota S, Kuroiwa Y, Nishioka K Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective. Infect Dis News, Opin Train. 2020;9(4):13-25. doi:10.33029/2305-3496-2020-9-4-13-25.Yokota S, Kuroiwa Y, Nishioka K Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective. Infect Dis News, Opin Train. 2020;9(4):13-25. doi:10.33029/2305-3496-2020-9-4-13-25.Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc. 2020;95(6):1213-21. doi:10.1016/j.mayocp.2020.03.024.Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc. 2020;95(6):1213-21. doi:10.1016/j.mayocp.2020.03.024.Sardu C, Gambardella J, Morelli MB, et al. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med. 2020;9(5):1417. doi:10.3390/jcm9051417.Sardu C, Gambardella J, Morelli MB, et al. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med. 2020;9(5):1417. doi:10.3390/jcm9051417.Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19 — related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Hear Rhythm. 2020;17(9):1463-71. doi:10.1016/j.hrthm.2020.05.001.Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19 — related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Hear Rhythm. 2020;17(9):1463-71. doi:10.1016/j.hrthm.2020.05.001.Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265. doi:10.1001/jamacardio.2020.3557.Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265. doi:10.1001/jamacardio.2020.3557.Кактурский Л. В., Михалева Л. М., Мишнев О. Д. и др. Синдром Такоцубо (стресс-индуцированная кардиомиопатия). Архив патологии. 2021;83(1):5-11. doi:10.17116/patol2021830115.Kakturskiy LV, Mikhaleva LM, Mishnev OD, et al. Takotsubo syndrome (stress-induced cardiomyopathy). Arkh Patol. 2021;83(1):5. (In Russ.) doi:10.17116/patol2021830115.Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi:10.1001/jamanetworkopen.2020.14780.Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi:10.1001/jamanetworkopen.2020.14780.Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866-1878. doi:10.1093/eurheartj/ehab075.Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866-1878. doi:10.1093/eurheartj/ehab075.Tersalvi G, Winterton D, Cioffi GM, et al. Telemedicine in Heart Failure During COVID-19: A Step Into the Future. Front Cardiovasc Med. 2020;7:612818. doi:10.3389/fcvm.2020.612818.Tersalvi G, Winterton D, Cioffi GM, et al. Telemedicine in Heart Failure During COVID-19: A Step Into the Future. Front Cardiovasc Med. 2020;7:612818. doi:10.3389/fcvm.2020.612818.Einstein AJ, Shaw LJ, Hirschfeld C, et al. International Impact of COVID-19 on the Diagnosis of Heart Disease. J Am Coll Cardiol. 2021;77(2):173-85. doi:10.1016/j.jacc.2020.10.054.Einstein AJ, Shaw LJ, Hirschfeld C, et al. International Impact of COVID-19 on the Diagnosis of Heart Disease. J Am Coll Cardiol. 2021;77(2):173-85. doi:10.1016/j.jacc.2020.10.054.De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083-8. doi:10.1093/eurheartj/ehaa409.De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083-8. doi:10.1093/eurheartj/ehaa409.Бунова С. С., Жернакова Н. И., Федорин М. М. и др. Эффективная антигипертензивная терапия: фокус на управление приверженностью. Кардиоваскулярная терапия и профилактика. 2020;19(5):2663. doi:10.15829/1728-8800-2020-2663.Bunova SS, Zhernakova NI, Fedorin MM, et al. Effective antihypertensive therapy: focus on adherence management. Cardiovascular Therapy and Prevention. 2020;19(5):2663. (In Russ.) doi:10.15829/1728-8800-2020-2663.Марцевич С. Ю., Кутишенко Н. П., Лукина Ю. В. и др. Самоконтроль и лечение хронических неинфекционных заболеваний в условиях пандемии COVID-19. Консенсус экспертов Национального общества доказательной фармакотерапии и Российского общества профилактики неинфекционных заболеваний. Кардиоваскулярная терапия и профилактика. 2020;19(3):2567. doi:10.15829/1728-8800-2020-2567.Martsevich SYu, Kutishenko NP, Lukina YuV, et al. Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases. Cardiovascular Therapy and Prevention. 2020;19(3):2567. (In Russ.) doi:10.15829/1728-8800-2020-2567.Vervoort D, Luc JGY, Percy E, et al. Assessing the Collateral Damage of the Novel Coronavirus: A Call to Action for the Post-COVID-19 Era. Ann Thorac Surg. 2020;110(3):757-60. doi:10.1016/j.athoracsur.2020.04.015.Vervoort D, Luc JGY, Percy E, et al. Assessing the Collateral Damage of the Novel Coronavirus: A Call to Action for the Post-COVID-19 Era. Ann Thorac Surg. 2020;110(3):757-60. doi:10.1016/j.athoracsur.2020.04.015.COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (UK). https://www.nice.org.uk/guidance/ng188 (11 June 2021).COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (UK). https://www.nice.org.uk/guidance/ng188 (11 June 2021).Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. doi:10.1016/S0140-6736(20)32656-8.Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. doi:10.1016/S0140-6736(20)32656-8.Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. doi:10.15585/mmwr.mm6930e1.Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. doi:10.15585/mmwr.mm6930e1.Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of selfreported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037-40. doi:10.1038/s41591-020-0916-2.Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of selfreported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037-40. doi:10.1038/s41591-020-0916-2.Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. doi:10.1038/s41591-021-01292-y.Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. doi:10.1038/s41591-021-01292-y.Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603. doi:10.1001/jama.2020.12603.Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603. doi:10.1001/jama.2020.12603.Yancy CW, Fonarow GC. Coronavirus Disease 2019 (COVID-19) and the Heart — Is Heart Failure the Next Chapter? JAMA Cardiol. 2020;5(11):1216. doi:10.1001/jamacardio.2020.3575.Yancy CW, Fonarow GC. Coronavirus Disease 2019 (COVID-19) and the Heart — Is Heart Failure the Next Chapter? JAMA Cardiol. 2020;5(11):1216. doi:10.1001/jamacardio.2020.3575.Starfield B, Shi L, Macinko J. Contribution of Primary Care to Health Systems and Health. Milbank Q. 2005;83(3):457-502. doi:10.1111/j.1468-0009.2005.00409.x.Starfield B, Shi L, Macinko J. Contribution of Primary Care to Health Systems and Health. Milbank Q. 2005;83(3):457-502. doi:10.1111/j.1468-0009.2005.00409.x.Greenhalgh T, Knight M, A’Court C, et al. Management of postacute COVID-19 in primary care. BMJ. 2020:m3026. doi:10.1136/bmj.m3026.Greenhalgh T, Knight M, A’Court C, et al. Management of postacute COVID-19 in primary care. BMJ. 2020:m3026. doi:10.1136/bmj.m3026.Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit. Crit Care Med. 2012;40(2):502-9. doi:10.1097/CCM.0b013e318232da75.Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit. Crit Care Med. 2012;40(2):502-9. doi:10.1097/CCM.0b013e318232da75.Kamdar BB, Suri R, Suchyta MR, et al. Return to work after critical illness: a systematic review and meta-analysis. Thorax. 2020;75(1):17-27. doi:10.1136/thoraxjnl-2019-213803.Kamdar BB, Suri R, Suchyta MR, et al. Return to work after critical illness: a systematic review and meta-analysis. Thorax. 2020;75(1):17-27. doi:10.1136/thoraxjnl-2019-213803.Bhala N, Curry G, Martineau AR, et al. Sharpening the global focus on ethnicity and race in the time of COVID-19. Lancet. 2020;395(10238):1673-6. doi:10.1016/S0140-6736(20)31102-8.Bhala N, Curry G, Martineau AR, et al. Sharpening the global focus on ethnicity and race in the time of COVID-19. Lancet. 2020;395(10238):1673-6. doi:10.1016/S0140-6736(20)31102-8.

The authors declare that there are no conflicts of interest present.